| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63dfc8b1bce837a93a49230c74be18f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c17b4872eb33eb876830bd26395018cf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04 |
| filingDate |
1991-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1633cbc3f4354c8b882f779db62b7bf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60200414f41074ae601bce11fce4c210 |
| publicationDate |
1993-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0547166-A1 |
| titleOfInvention |
Pathogen-specific ctl therapy |
| abstract |
The invention describes a method of treating a patient infected with an intracellular pathogen, which comprises administering to the patient a stimulating antigen of cytotoxic T lymphocytes specific for intracellular pathogens, or an enriched preparation of the lymphocytes of the patient. by cytotoxic T lymphocytes, specific for intracellular pathogens. |
| priorityDate |
1990-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |